Skip to main content

Table 1 Demographic and clinical data

From: Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma

  n Age enrolled in our study (month) Gender (female/male) Tumor stage Treatment before serum collection
Healthy children 10 41.9 ± 1.7 5/5
NB 20 44.5 ± 6.4 9/11 I: 4
II: 9
III: 6
IV: 1
13 children: no treatment
7 children: chemotherapy, receiving vincristine, cyclophosphamide, adriamycin, etoposide, and cisplatin
OMS + NB 10 35.6 ± 9.9 5/5 I: 3
II: 4
III: 3
IV: 0
8 children: no treatment
1 child: steroid
1 child: intravenous immune globulin
Juvenile idiopathic arthritis (JIA) 10 40.8 ± 10.5 6/4 6 children: no treatment
3 children: nonsteroidal anti-inflammatory drugs
1 child: received steroid
Anti-NDMAR encephalitis 6 54.3 ± 9.9 4/2 2 children: no treatment
4 children: steroid and intravenous immune globulin